- $2.05bn
- $1.76bn
- $2.50bn
Annual income statement for Pattern, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 991 | 1,366 | 1,796 | 2,501 |
| Cost of Revenue | ||||
| Gross Profit | 429 | 601 | 781 | 1,090 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Total Operating Expenses | 986 | 1,314 | 1,709 | 2,476 |
| Operating Profit | 4.12 | 52.8 | 87.2 | 25.4 |
| Total Net Non Operating Interest Income / Expense | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -1.69 | 56.3 | 91.2 | -0.794 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -2.98 | 41.3 | 67.9 | 16.2 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -2.98 | 41.3 | 67.9 | 16.2 |
| Adjustments to Net Income | ||||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -21 | 19.8 | 42.5 | -157 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.084 | 0.11 | 0.244 | -1.33 |